Combination of Bortezomib Plus Ruxolitinib in Steroid-Refractory Chronic Graft-Versus-Host Disease

Bone Marrow Transplantation - United Kingdom
doi 10.1038/s41409-018-0362-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Late Onset and Protracted Course of Steroid Refractory Chronic Graft-Versus-Host Disease

Case Reports in Hematology
2015English

Tocilizumab for Steroid Refractory Acute Graft-Versus-Host Disease

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2015English

Ruxolitinib as a Promising Treatment for Corticosteroid-Refractory Graft-Versus -Host Disease

British Journal of Haematology
Hematology
2017English

Sirolimus for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2009English

Outcomes of Infliximab in Management of Steroid-Refractory Acute Graft Versus Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Imatinib Mesylate for the Treatment of Steroid-Refractory Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Response to Thalidomide Therapy in Refractory Chronic Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2000English

Etanercept as Treatment of Steroid-Refractory Acute Graft Versus Host Disease in Pediatric Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Psy14 - Clinical Response to Systemic Treatments for Steroid-Refractory Chronic Graft-Versus-Host Disease: A Systematic Literature Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy